The “Red Book,” officially known as the “Guidelines for Preventive Activities in General Practice,” categorizes breast cancer risk into three groups: low, moderate, and high.
- Low Risk: Most women fall into this category, with a lifetime risk of less than 4%.
- This group typically includes women with
- no confirmed family history of breast cancer
- one first-degree relative diagnosed with breast cancer at age 50 or older
- one second-degree relative diagnosed with breast cancer at any age
- two second-degree relatives on the same side of the family diagnosed with breast cancer aged 50 or older, or
- two first-degree or second-degree relatives diagnosed with breast cancer aged 50 or older but on different sides of the family.
- The relative risk of breast cancer up to 75 years of age for this group is between 1:11 and 1:8.
- This group typically includes women with
- Moderately Increased Risk: This group constitutes less than 4% of the female population.
- It includes women with
- one first-degree relative diagnosed with breast cancer before age 50
- two first-degree relatives on the same side of the family diagnosed with breast cancer, or
- two second-degree relatives on the same side of the family diagnosed with breast cancer, at least one of whom was diagnosed before age 50.
- The relative risk of breast cancer for this group up to 75 years of age is between 1:8 and 1:4.
- It includes women with
- High Risk: Women in this category are at a risk more than 3 times the population risk.
- This group includes women with
- additional relatives with breast or ovarian cancer, breast cancer diagnosed before age 40, bilateral breast cancer, both breast and ovarian cancer in the same woman,
- Ashkenazi Jewish ancestry,
- breast cancer in a male relative,
- one first-degree or second-degree relative diagnosed with breast cancer before age 45 plus another first-degree or second-degree relative on the same side of the family with sarcoma (bone/soft tissue) aged under 45, or members of a family in which a high-risk breast cancer gene mutation has been established.
- This group includes women with
For women at moderate or high risk, additional interventions such as risk-reducing medication (moderate and high risk) and risk-reducing surgery (high risk) are available. Referral to specialist genetic assessment is recommended for women assessed at high risk.